Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.57 Million ≈ $1.25 Million USD) by net assets (CN¥1.62 Billion ≈ $236.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603168 equity to assets ratio to measure how much of total assets are equity-financed.
Zhejiang Shapuaisi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhejiang Shapuaisi Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Shapuaisi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Norwood Financial Corp
NASDAQ:NWFL
|
0.039x |
|
LEXINFINTECH ADR/2 CL.A
F:1LFA
|
N/A |
|
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd
SHE:300313
|
-0.931x |
|
Orell Fuessli Holding AG
SW:OFN
|
0.274x |
|
Austindo Nusantara Jaya Tbk
JK:ANJT
|
-0.022x |
|
ANTENGENE CORP. DL-0001
F:722
|
N/A |
|
Spectral Med Inc
TO:EDT
|
0.039x |
|
Siddhi Acquisition Corp Class A Common stock
NASDAQ:SDHI
|
-0.001x |
Annual Cash Flow Conversion Efficiency for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.59 Billion ≈ $232.62 Million |
CN¥25.67 Million ≈ $3.76 Million |
0.016x | -32.69% |
| 2023-12-31 | CN¥1.73 Billion ≈ $253.06 Million |
CN¥41.49 Million ≈ $6.07 Million |
0.024x | -64.41% |
| 2022-12-31 | CN¥1.72 Billion ≈ $251.20 Million |
CN¥115.72 Million ≈ $16.93 Million |
0.067x | -9.54% |
| 2021-12-31 | CN¥1.35 Billion ≈ $197.91 Million |
CN¥100.78 Million ≈ $14.75 Million |
0.075x | +120.75% |
| 2020-12-31 | CN¥1.31 Billion ≈ $191.13 Million |
CN¥44.09 Million ≈ $6.45 Million |
0.034x | -15.48% |
| 2019-12-31 | CN¥1.49 Billion ≈ $217.89 Million |
CN¥59.47 Million ≈ $8.70 Million |
0.040x | -41.06% |
| 2018-12-31 | CN¥1.48 Billion ≈ $216.74 Million |
CN¥100.37 Million ≈ $14.69 Million |
0.068x | +146.44% |
| 2017-12-31 | CN¥1.66 Billion ≈ $242.51 Million |
CN¥45.57 Million ≈ $6.67 Million |
0.027x | -85.11% |
| 2016-12-31 | CN¥1.59 Billion ≈ $233.29 Million |
CN¥294.33 Million ≈ $43.07 Million |
0.185x | +44.05% |
| 2015-12-31 | CN¥891.62 Million ≈ $130.47 Million |
CN¥114.27 Million ≈ $16.72 Million |
0.128x | -33.93% |
| 2014-12-31 | CN¥762.90 Million ≈ $111.64 Million |
CN¥147.99 Million ≈ $21.66 Million |
0.194x | -41.85% |
| 2013-12-31 | CN¥353.31 Million ≈ $51.70 Million |
CN¥117.86 Million ≈ $17.25 Million |
0.334x | +35.99% |
| 2012-12-31 | CN¥274.21 Million ≈ $40.13 Million |
CN¥67.27 Million ≈ $9.84 Million |
0.245x | +227.15% |
| 2011-12-31 | CN¥201.95 Million ≈ $29.55 Million |
CN¥15.14 Million ≈ $2.22 Million |
0.075x | -35.10% |
| 2010-12-31 | CN¥152.04 Million ≈ $22.25 Million |
CN¥17.57 Million ≈ $2.57 Million |
0.116x | -56.11% |
| 2009-12-31 | CN¥109.67 Million ≈ $16.05 Million |
CN¥28.87 Million ≈ $4.22 Million |
0.263x | +120.01% |
| 2008-12-31 | CN¥93.58 Million ≈ $13.69 Million |
CN¥11.20 Million ≈ $1.64 Million |
0.120x | -- |
About Zhejiang Shapuaisi Pharmaceutical Co Ltd
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi… Read more